BioCentury
ARTICLE | Company News

1st Biotherapeutics, twoXAR to use AI to discover glioblastoma candidates

January 11, 2019 5:36 PM UTC

1st Biotherapeutics Inc. (Seongnam, South Korea) and twoXAR Inc. (Mountain View, Calif.) partnered to discover and develop treatments for glioblastoma multiforme. twoXAR will use its AI technology to identify candidates, and both companies will determine which candidates to test in preclinical glioblastoma models. 1st Biotherapeutics will then be responsible for further development...